Skip to content
MedsAcross

Medicine

Protamine 50 mg/5 mL injection

Protamine · Intravenous
Available on requestPrescription onlyUS FDAGeneric name

Protamine 50 mg/5 mL injection is a generic prescription medicine for intravenous use, made by 2 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

Do not permit to freeze. Store at 20° to 25°C (68° to 77°F).

Key facts

Active ingredient (INN)
Protamine
Brand
Sold under the generic name
Strength
50 mg/5 mL
Dosage form
Injection
Route
Intravenous
Packs
25 vials of 5 mL, 5 mL, 25 pouches of 5 mL and 3 more
Manufacturers
Fresenius KabiHealthFirst
Origin register
US FDA, United States
Storage
Do not permit to freeze. Store at 20° to 25°C (68° to 77°F).
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
ATC code
V03AB14 Protamine
HS code (indicative)
3004.90Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
18 October 2000
Identifiers
RxCUI 1796672, 1796676DailyMed set ID 94d4f57f-940e-c0a8-e053-2a95a90ae3af, c76876da-b9a8-45d0-9278-7df3288d3a06, 8df0a819-9e1a-44ce-97a6-3ea82c867d44 +2NDC 51662-1414, 65219-646, 63323-229Application ANDA089454

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

Packs from every labeler of this generic presentation.

PackCodeLabelerMarketed since
25 vial, single-dose in 1 tray / 5 mL in 1 vial, single-dose63323-229-05Fresenius Kabi18 October 2000
25 vial, single-dose in 1 tray / 5 mL in 1 vial, single-dose63323-229-15Fresenius Kabi18 October 2000
25 vial, single-dose in 1 tray / 5 mL in 1 vial, single-dose63323-229-94Fresenius Kabi18 October 2000
25 vial, single-dose in 1 tray / 5 mL in 1 vial, single-dose65219-646-05Fresenius Kabi28 March 2025
5 mL in 1 vial, single-dose51662-1414-1HealthFirst13 October 2019
25 pouch in 1 case / 1 vial, single-dose in 1 pouch / 5 mL in 1 vial, single-dose51662-1414-3HealthFirst16 June 2023

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 13 August 1969Drugs@FDA
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Other strengths and forms of Protamine

Clinical summary

Protamine is a heparin reversal agent indicated in the treatment of heparin overdosage. It is available as injection for intravenous use. MedsAcross supplies Protamine for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Protamine

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Protamine 50 mg/5 mL injection for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.